Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.84 EUR | +2.13% | +3.78% | +9.09% |
Quotes 5-day view
Delayed Quote Deutsche Boerse AG2024-06-26 | 2024-06-27 | 2024-06-28 | 2024-07-01 | |
---|---|---|---|---|
Last | 3.68 € | 3.74 € | 3.76 € | 3.84 € |
Change | -0.54% | +1.63% | +0.53% | +2.13% |
Performance
1 day | +2.13% | ||
1 week | +3.78% | ||
Current month | +2.13% | ||
1 month | -1.54% | ||
3 months | +3.78% | ||
6 months | +9.09% | ||
Current year | +9.09% | ||
1 year | +16.36% | ||
3 years | +9.09% | ||
5 years | -25.80% | ||
10 years | +6.96% |
Volumes
marketsBasic data
Highs and lows
Indicators
Sector Comparison - Specialty & Advanced Pharmaceuticals
Name | Change | 5d. change | 1st Jan change | 1-year change | Capi. | |
---|---|---|---|---|---|---|
+2.13% | +3.78% | +9.09% | +16.36% | 420M | ||
-1.30% | -0.45% | +15.40% | +1.88% | 9.05B | ||
+1.81% | +3.41% | -21.41% | -2.47% | 4.4B | ||
+3.58% | +7.44% | +21.80% | +45.68% | 4.39B | ||
+0.85% | -3.18% | +27.00% | +51.62% | 3.94B | ||
-0.81% | -5.09% | +3.80% | -32.53% | 2.1B | ||
+3.46% | +4.84% | +12.87% | -2.13% | 1.97B | ||
+3.38% | -1.03% | -34.72% | -29.94% | 1.87B | ||
-.--% | -.--% | - | - | 1.64B | ||
+9.59% | +9.70% | -43.28% | -50.34% | 1.61B | ||
-0.75% | -1.34% | -8.26% | -11.68% | 1.47B | ||
+1.29% | -6.32% | -13.37% | -13.17% | 1.1B | ||
+0.10% | +0.10% | +61.92% | +137.37% | 1.04B | ||
+10.25% | +16.78% | +79.61% | +78.45% | 1.04B | ||
-3.18% | -7.14% | -22.37% | -24.73% | 979M | ||
-0.62% | -0.47% | +3.88% | +9.52% | 896M | ||
Average | +1.86% | +2.02% | +6.13% | +11.59% | ||
Weighted average by Cap. | +1.33% | +1.87% | +6.93% | +10.59% |
Historical data
Date | Opening | High | Low | End-of-day | Volume |
---|
Monthly variations
Annual change
2024 | +9.09% | ||
2023 | -3.30% | ||
2022 | +1.11% | ||
2021 | +9.09% | ||
2020 | -35.92% | ||
2019 | +7.97% | ||
2018 | -8.76% | ||
2017 | -27.30% | ||
2016 | +44.92% | ||
2015 | +3.31% | ||
2014 | +25.57% |
- Stock Market
- Equities
- GUD Stock
- 04K Stock
- Quotes Knight Therapeutics Inc.